Publications by authors named "Wojciech Senkowski"

Claim this Profile
D
Decoding the Genomic and Functional Landscape of Emerging Subtypes in Ovarian Cancer.
Giulia Micoli, Kari Lavikka, Yilin Li, Anna Pirttikoski, Daria Afenteva, Wojciech Senkowski

Cancer Discov· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a TNIK-CDK9 Axis as a Targetable Strategy for Platinum-Resistant Ovarian Cancer.
Noah Puleo, Harini Ram, Michele L Dziubinski, Dylan Carvette, Jessica Teitel, Wojciech Senkowski

Mol Cancer Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones.
Aleksandr Ianevski, Kristen Nader, Kyriaki Driva, Wojciech Senkowski, Daria Bulanova

Nat Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cells.
Daria Bulanova, Yevhen Akimov, Wojciech Senkowski, Jaana Oikkonen, Laura Gall-Mas

Sci Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of cell death and proliferation of patient-derived ovarian cancer organoids through 3D imaging and image analysis.
Aikaterini Skorda, Anna Røssberg Lauridsen, Kaisa Huhtinen, Alexandra Lahtinen, Wojciech Senkowski

STAR Protoc· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids.
Wojciech Senkowski, Laura Gall-Mas, Matías Marín Falco, Yilin Li, Kari Lavikka

Dev Cell· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma.
Alexandra Lahtinen, Kari Lavikka, Anni Virtanen, Yilin Li, Sanaz Jamalzadeh, Wojciech Senkowski

Cancer Cell· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma.
Frida Ek, Kristin Blom, Tove Selvin, Jakob Rudfeldt, Claes Andersson, Wojciech Senkowski

Sci Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective radiosensitization by nitazoxanide of quiescent clonogenic colon cancer tumour cells.
Henning Karlsson, Mårten Fryknäs, Wojciech Senkowski, Rolf Larsson, Peter Nygren

Oncol Lett· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditions for maintenance of hepatocyte differentiation and function in 3D cultures.
Niklas Handin, Evgeniya Mickols, Magnus Ölander, Jakob Rudfeldt, Kristin Blom, Wojciech Senkowski

iScience· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Descriptive Proteome Analysis to Investigate Context-Dependent Treatment Responses to OXPHOS Inhibition in Colon Carcinoma Cells Grown as Monolayer and Multicellular Tumor Spheroids.
Julia Steinmetz, Wojciech Senkowski, Johan Lengqvist, Jenny Rubin, Elena Ossipova

ACS Omega· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel tumor spheroid model identifies selective enhancement of radiation by an inhibitor of oxidative phosphorylation.
Henning Karlsson, Wojciech Senkowski, Mårten Fryknäs, Sharmineh Mansoori, Stig Linder

Oncotarget· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting tumor cells based on Phosphodiesterase 3A expression.
Madiha Nazir, Wojciech Senkowski, Frida Nyberg, Kristin Blom, Per-Henrik Edqvist

Exp Cell Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation.
Kristin Blom, Wojciech Senkowski, Malin Jarvius, Malin Berglund, Jenny Rubin

Immunopharmacol Immunotoxicol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron chelators target both proliferating and quiescent cancer cells.
Mårten Fryknäs, Xiaonan Zhang, Ulf Bremberg, Wojciech Senkowski, Maria Hägg Olofsson

Sci Rep· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
Wojciech Senkowski, Malin Jarvius, Jenny Rubin, Johan Lengqvist, Mats G Gustafsson

Cell Chem Biol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer.
Wojciech Senkowski, Xiaonan Zhang, Maria Hägg Olofsson, Ruben Isacson, Urban Höglund

Mol Cancer Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis